10.1146/annurev.ph.57.030195.000315 37
Decision Guidance Choose cagrilintide + retatrutide when you want maximum theoretical pathway coverage and you accept higher cost, complexity, and uncertainty
You will get a chance to look for the right treatment, depending on your needs, and speak with a nurse about your health goals
Any of these warrant a protocol reassessment and potentially a conversation with a healthcare provider
The peptide inhibited hyperglycemia-induced epithelial-mesenchymal transition (EMT) and downregulated fibrosis-related genes, preventing the subretinal fibrosis that represents end-stage proliferative diabetic retinopathy
So if you have knowledge of a given cancer or you're concerned, about tumors at all, I would encourage you to be very cautious about the use of BPC-157